347 related articles for article (PubMed ID: 31588538)
1. Nephrogenic Diabetes Insipidus.
Balla A; Hunyady L
Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
[TBL] [Abstract][Full Text] [Related]
3. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
5. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.
Bockenhauer D; Bichet DG
Nat Rev Nephrol; 2015 Oct; 11(10):576-88. PubMed ID: 26077742
[TBL] [Abstract][Full Text] [Related]
7. Regulation of aquaporin-2 trafficking.
Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
[TBL] [Abstract][Full Text] [Related]
8. Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.
Ando F; Uchida S
Clin Exp Nephrol; 2018 Jun; 22(3):501-507. PubMed ID: 29478202
[TBL] [Abstract][Full Text] [Related]
9. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
10. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
11. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
12. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
Ando F
Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
[TBL] [Abstract][Full Text] [Related]
13. Aquaporins in Diabetes Insipidus.
Lu HAJ; He J
Adv Exp Med Biol; 2023; 1398():267-279. PubMed ID: 36717500
[TBL] [Abstract][Full Text] [Related]
14. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
Ando F; Mori S; Yui N; Morimoto T; Nomura N; Sohara E; Rai T; Sasaki S; Kondo Y; Kagechika H; Uchida S
Nat Commun; 2018 Apr; 9(1):1411. PubMed ID: 29650969
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
[TBL] [Abstract][Full Text] [Related]
17. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
Procino G; Milano S; Carmosino M; Barbieri C; Nicoletti MC; Li JH; Wess J; Svelto M
Kidney Int; 2014 Jul; 86(1):127-38. PubMed ID: 24522493
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.
Ranieri M; Tamma G; Pellegrino T; Vezzi V; Ambrosio C; Grò C; Di Mise A; Costa T; Valenti G; Cotecchia S
Pflugers Arch; 2019 Oct; 471(10):1291-1304. PubMed ID: 31486901
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
Loonen AJ; Knoers NV; van Os CH; Deen PM
Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary nephrogenic diabetes insipidus].
Morin D; Ala Y; Dumas R
Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
